Very good.
Improved standardised procedures.
Improved sensitivity
Letting us know they're now into the nitty gritty of voltage biases and the whole transistor development , like the 12CQ
Expanded to the US as well, great news.
All in my opinion and I am less familiar with the gFET,
This is now starting to look like progress. Have to just get these testing processes done. Tweaks are less complex than what has to happen with the 12CQ
The market for the biochip is a more targeted one. Less necessity to look for scaling opportunities with big foundries.
We could well see some action here this year in terms of actual testing with bio samples.
Very good. Improved standardised procedures.Improved...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $67.53M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 27.0¢ | 26.0¢ | $29.40K | 111.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5962 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 40677 | 2 |
View Market Depth
| Last trade - 15.25pm 05/11/2024 (20 minute delay) ? |
| AXE (ASX) Chart |